Arcturus Therapeutics Holdings Inc. Company profile
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) develops RNA-based medicines using its proprietary lipid nanoparticle and self-amplifying mRNA platforms. The company’s pipeline includes vaccines, liver-targeted therapies, and respiratory treatments with partnerships across major global health organizations. Arcturus’s shares move with clinical trial progress, regulatory milestones, and investor sentiment toward the mRNA therapeutics sector.Latest shares articles



